GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 13 filers reported holding GENETIC TECHNOLOGIES LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $12,060 | -70.6% | 10,308 | -71.5% | 0.00% | – |
Q2 2022 | $41,000 | -70.7% | 36,117 | -49.2% | 0.00% | – |
Q1 2022 | $140,000 | -30.7% | 71,158 | -33.7% | 0.00% | – |
Q4 2021 | $202,000 | -27.6% | 107,355 | +18.7% | 0.00% | – |
Q3 2021 | $279,000 | -26.6% | 90,472 | +1.3% | 0.00% | – |
Q2 2021 | $380,000 | -49.1% | 89,352 | -50.1% | 0.00% | – |
Q1 2021 | $746,000 | +73.5% | 178,890 | +49.6% | 0.00% | – |
Q4 2020 | $430,000 | +198.6% | 119,573 | +188.1% | 0.00% | – |
Q3 2020 | $144,000 | – | 41,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Scarborough Advisors, LLC | 10,638 | $8,113 | 0.00% |
RHUMBLINE ADVISERS | 18,700 | $14,378 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 87,656 | $66,846 | 0.00% |
TWO SIGMA SECURITIES, LLC | 15,844 | $12,083 | 0.00% |